首页 | 本学科首页   官方微博 | 高级检索  
   检索      


RXR-LXR heterodimer modulators for the potential treatment of dyslipidemia
Authors:Lagu Bharat  Pio Barbara  Lebedev Rimma  Yang Maria  Pelton Patricia D
Institution:Johnson and Johnson Pharmaceutical Research and Development, Cranbury, NJ 08869, USA. blagu@prdus.jnj.com
Abstract:A number of RXR agonists were synthesized and screened in functional assays. The synthesis and the structure-activity relationship (SAR) within the series of compounds will be presented. Some in vivo data in rodent models for dyslipidemia and diabetes will also be presented.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号